Suppr超能文献

过表达刺猬信号通路受体Patched的癌细胞亚群的持续特性

Persistent Properties of a Subpopulation of Cancer Cells Overexpressing the Hedgehog Receptor Patched.

作者信息

Feliz Morel Álvaro Javier, Hasanovic Anida, Morin Aurélie, Prunier Chloé, Magnone Virginie, Lebrigand Kevin, Aouad Amaury, Cogoluegnes Sarah, Favier Judith, Pasquier Claude, Mus-Veteau Isabelle

机构信息

Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), 06560 Valbonne, France.

Université de Paris, PARCC, INSERM, Equipe Labellisée par la Ligue Contre le Cancer, CEDEX 15, 75737 Paris, France.

出版信息

Pharmaceutics. 2022 May 5;14(5):988. doi: 10.3390/pharmaceutics14050988.

Abstract

Despite the development of new therapeutic strategies, cancer remains one of the leading causes of mortality worldwide. One of the current major challenges is the resistance of cancers to chemotherapy treatments inducing metastases and relapse of the tumor. The Hedgehog receptor Patched (Ptch1) is overexpressed in many types of cancers. We showed that Ptch1 contributes to the efflux of doxorubicin and plays an important role in the resistance to chemotherapy in adrenocortical carcinoma (ACC), a rare cancer which presents strong resistance to the standard of care chemotherapy treatment. In the present study, we isolated and characterized a subpopulation of the ACC cell line H295R in which Ptch1 is overexpressed and more present at the cell surface. This cell subpopulation is more resistant to doxorubicin, grows as spheroids, and has a greater capability of clonogenicity, migration, and invasion than the parental cells. Xenograft experiments performed in mice and in ovo showed that this cell subpopulation is more tumorigenic and metastatic than the parental cells. These results suggest that this cell subpopulation has cancer stem-like or persistent cell properties which were strengthened by RNA-seq. If present in tumors from ACC patients, these cells could be responsible for therapy resistance, relapse, and metastases.

摘要

尽管新的治疗策略不断发展,但癌症仍然是全球主要的死亡原因之一。当前的主要挑战之一是癌症对化疗产生耐药性,从而导致肿瘤转移和复发。刺猬信号通路受体Patched(Ptch1)在多种癌症中过度表达。我们发现,Ptch1促进阿霉素外排,并在肾上腺皮质癌(ACC)对化疗的耐药性中起重要作用,肾上腺皮质癌是一种对标准护理化疗治疗具有强烈耐药性的罕见癌症。在本研究中,我们分离并鉴定了ACC细胞系H295R的一个亚群,其中Ptch1过度表达且更多地存在于细胞表面。该细胞亚群对阿霉素更具耐药性,呈球体生长,并且与亲代细胞相比具有更强的克隆形成、迁移和侵袭能力。在小鼠和鸡胚中进行的异种移植实验表明,该细胞亚群比亲代细胞更具致瘤性和转移性。这些结果表明,该细胞亚群具有癌症干细胞样或持久性细胞特性,RNA测序进一步强化了这些特性。如果存在于ACC患者的肿瘤中,这些细胞可能是治疗耐药性、复发和转移的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef7/9146430/4ed9bd341f8b/pharmaceutics-14-00988-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验